FDA-approved digital therapeutic for amblyopia. Launching Q2 2022.
FDA-approved digital therapeutic for amblyopia. Launching Q2 2022.
It leads to missing out in school, sports, work, and everyday life.
It can even cause permanent vision loss.
“ Luminopia One is following a path that promises to transform clinical practice.”
“ Luminopia’s novel technologies and innovative approach promise to transform the future of visual care and beyond.”
“ I feel like I’m sitting near Alexander Graham Bell while making the first phone call. This has the potential to change the way we practice medicine.”
“ Combining the principles of synaptic plasticity and amblyopia treatment is a truly exciting prospect!”
Luminopia One is a digital therapeutic built on years of cutting-edge science. Our neuroscience-based approach works by presenting TV and movie content differently to each eye within a kid-friendly virtual reality (VR) headset. Thanks to powerful neural plasticity, this rebalancing approach strengthens visual processing, promotes weaker eye usage, and encourages both eyes to work together properly!
At Luminopia, we place a strong emphasis on rigorous clinical research to show that our products are safe and effective for children. To date, we have conducted several clinical trials on Luminopia One in collaboration with leading hospitals and research institutions across the United States. These studies, including a prospective, randomized controlled trial, have demonstrated the potential for Luminopia One to be an engaging and effective at-home therapy for amblyopia. Luminopia One has been approved by the FDA for prescription use, and is indicated for improvement in visual acuity in amblyopia patients aged 4-7.
Director of The Wilmer Eye Institute
Ophthalmologist-in-Chief, Boston Children’s Hospital
Chief of Division of Ophthalmology, Children's Hospital of Philadelphia
Clinical Professor of Ophthalmology, New York University Langone Medical Center
Professor of Neuroscience at MIT’s Picower Institute for Learning and Memory
Institute Professor at MIT; Co-Founder of Moderna; Most cited engineer in history
Chief Innovation Officer for Creative Artists Agency; Co-Founder of TIME’S UP
Executive Chairman at Sesame Workshop; Former COO of Nickelodeon Networks
Chief Business Officer at Immunai; Former Chief User Engagement Officer at Guardant Health
Luminopia One works by modifying popular TV shows and movies into therapeutic visual stimuli within a VR headset. With a broad library of beloved content available, all you have to do is pick a video and enjoy as we take care of the rest!
Our simple software application places you into an immersive world that makes it easy to select content and receive therapy.
In addition to the therapy, our cloud-based online platform provides insights into your usage, helping you stay on track!